Akumin (Akumin) Growth Rank : 9 (As of May. 03, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Akumin Growth Rank?

Akumin has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Akumin's Growth Rank

For the Diagnostics & Research subindustry, Akumin's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akumin's Growth Rank Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Growth Rank distribution charts can be found below:

* The bar in red indicates where Akumin's Growth Rank falls into.

Akumin Growth Rank Related Terms

Thank you for viewing the detailed overview of Akumin's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (Akumin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

AKU:Canada

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Ronald J. Bienias	officer: Chief Restructuring Officer	C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar	officer: See remarks	C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer	officer: See Remarks	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp	10 percent owner	3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner	10 percent owner	3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis	officer: Chief Information Officer	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron	officer: See Remarks	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322